You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 4 No. 3, March 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Leukodystrophy and the Concept of Dysmyelination

CHARLES M. POSER, M.D.

Arch Neurol. 1961;4(3):323-332.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

The nosologic position of the leukodystrophies has long been controversial. The heredodegenerative diseases of the white matter of the central nervous system have received but scant attention in American medical literature in spite of the appearance of many case reports, review papers, and classifications in European journals during the past 40 years.

In 1957, after thorough study of available pathologic material and of the relevant literature, I proposed that two basic kinds of primary diseases of the myelin sheath existed.41 The first, the myelinoclastic type, comprises the true demyelinating diseases and includes disseminated sclerosis, diffuse sclerosis of the 1912 Schilder type,47 Devic's and Balo's diseases. In this type, the myelin sheath seems to be destroyed after having been normally constituted. The second type is exemplified by the leukodystrophies. In it there appears to be a disturbance of myelin anabolism. I suggested the term "dysmyelinating diseases" to identify . . . [Full Text PDF of this Article]


Author Affiliations

KANSAS CITY, KAN.

From the Section of Experimental Neurology, Department of Medicine, University of Kansas School of Medicine.


Footnotes

Received for publication Dec. 1, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.